Cargando…

PACmn for improved optogenetic control of intracellular cAMP

BACKGROUND: Cyclic adenosine monophosphate (cAMP) is a ubiquitous second messenger that transduces extracellular signals in virtually all eukaryotic cells. The soluble Beggiatoa photoactivatable adenylyl cyclase (bPAC) rapidly raises cAMP in blue light and has been used to study cAMP signaling pathw...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Shang, Constantin, Oana M., Sachidanandan, Divya, Hofmann, Hannes, Kunz, Tobias C., Kozjak-Pavlovic, Vera, Oertner, Thomas G., Nagel, Georg, Kittel, Robert J., Gee, Christine E., Gao, Shiqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522238/
https://www.ncbi.nlm.nih.gov/pubmed/34663304
http://dx.doi.org/10.1186/s12915-021-01151-9
_version_ 1784585052423716864
author Yang, Shang
Constantin, Oana M.
Sachidanandan, Divya
Hofmann, Hannes
Kunz, Tobias C.
Kozjak-Pavlovic, Vera
Oertner, Thomas G.
Nagel, Georg
Kittel, Robert J.
Gee, Christine E.
Gao, Shiqiang
author_facet Yang, Shang
Constantin, Oana M.
Sachidanandan, Divya
Hofmann, Hannes
Kunz, Tobias C.
Kozjak-Pavlovic, Vera
Oertner, Thomas G.
Nagel, Georg
Kittel, Robert J.
Gee, Christine E.
Gao, Shiqiang
author_sort Yang, Shang
collection PubMed
description BACKGROUND: Cyclic adenosine monophosphate (cAMP) is a ubiquitous second messenger that transduces extracellular signals in virtually all eukaryotic cells. The soluble Beggiatoa photoactivatable adenylyl cyclase (bPAC) rapidly raises cAMP in blue light and has been used to study cAMP signaling pathways cell-autonomously. But low activity in the dark might raise resting cAMP in cells expressing bPAC, and most eukaryotic cyclases are membrane-targeted rather than soluble. Our aim was to engineer a plasma membrane-anchored PAC with no dark activity (i.e., no cAMP accumulation in the dark) that rapidly increases cAMP when illuminated. RESULTS: Using a streamlined method based on expression in Xenopus oocytes, we compared natural PACs and confirmed bPAC as the best starting point for protein engineering efforts. We identified several modifications that reduce bPAC dark activity. Mutating a phenylalanine to tyrosine at residue 198 substantially decreased dark cyclase activity, which increased 7000-fold when illuminated. Whereas Drosophila larvae expressing bPAC in mechanosensory neurons show nocifensive-like behavior even in the dark, larvae expressing improved soluble (e.g., bPAC(R278A)) and membrane-anchored PACs exhibited nocifensive responses only when illuminated. The plasma membrane-anchored PAC (PACmn) had an undetectable dark activity which increased >4000-fold in the light. PACmn does not raise resting cAMP nor, when expressed in hippocampal neurons, affect cAMP-dependent kinase (PKA) activity in the dark, but rapidly and reversibly increases cAMP and PKA activity in the soma and dendrites upon illumination. The peak responses to brief (2 s) light flashes exceed the responses to forskolin-induced activation of endogenous cyclases and return to baseline within seconds (cAMP) or ~10 min (PKA). CONCLUSIONS: PACmn is a valuable optogenetic tool for precise cell-autonomous and transient stimulation of cAMP signaling pathways in diverse cell types. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12915-021-01151-9.
format Online
Article
Text
id pubmed-8522238
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-85222382021-10-22 PACmn for improved optogenetic control of intracellular cAMP Yang, Shang Constantin, Oana M. Sachidanandan, Divya Hofmann, Hannes Kunz, Tobias C. Kozjak-Pavlovic, Vera Oertner, Thomas G. Nagel, Georg Kittel, Robert J. Gee, Christine E. Gao, Shiqiang BMC Biol Research Article BACKGROUND: Cyclic adenosine monophosphate (cAMP) is a ubiquitous second messenger that transduces extracellular signals in virtually all eukaryotic cells. The soluble Beggiatoa photoactivatable adenylyl cyclase (bPAC) rapidly raises cAMP in blue light and has been used to study cAMP signaling pathways cell-autonomously. But low activity in the dark might raise resting cAMP in cells expressing bPAC, and most eukaryotic cyclases are membrane-targeted rather than soluble. Our aim was to engineer a plasma membrane-anchored PAC with no dark activity (i.e., no cAMP accumulation in the dark) that rapidly increases cAMP when illuminated. RESULTS: Using a streamlined method based on expression in Xenopus oocytes, we compared natural PACs and confirmed bPAC as the best starting point for protein engineering efforts. We identified several modifications that reduce bPAC dark activity. Mutating a phenylalanine to tyrosine at residue 198 substantially decreased dark cyclase activity, which increased 7000-fold when illuminated. Whereas Drosophila larvae expressing bPAC in mechanosensory neurons show nocifensive-like behavior even in the dark, larvae expressing improved soluble (e.g., bPAC(R278A)) and membrane-anchored PACs exhibited nocifensive responses only when illuminated. The plasma membrane-anchored PAC (PACmn) had an undetectable dark activity which increased >4000-fold in the light. PACmn does not raise resting cAMP nor, when expressed in hippocampal neurons, affect cAMP-dependent kinase (PKA) activity in the dark, but rapidly and reversibly increases cAMP and PKA activity in the soma and dendrites upon illumination. The peak responses to brief (2 s) light flashes exceed the responses to forskolin-induced activation of endogenous cyclases and return to baseline within seconds (cAMP) or ~10 min (PKA). CONCLUSIONS: PACmn is a valuable optogenetic tool for precise cell-autonomous and transient stimulation of cAMP signaling pathways in diverse cell types. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12915-021-01151-9. BioMed Central 2021-10-18 /pmc/articles/PMC8522238/ /pubmed/34663304 http://dx.doi.org/10.1186/s12915-021-01151-9 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Yang, Shang
Constantin, Oana M.
Sachidanandan, Divya
Hofmann, Hannes
Kunz, Tobias C.
Kozjak-Pavlovic, Vera
Oertner, Thomas G.
Nagel, Georg
Kittel, Robert J.
Gee, Christine E.
Gao, Shiqiang
PACmn for improved optogenetic control of intracellular cAMP
title PACmn for improved optogenetic control of intracellular cAMP
title_full PACmn for improved optogenetic control of intracellular cAMP
title_fullStr PACmn for improved optogenetic control of intracellular cAMP
title_full_unstemmed PACmn for improved optogenetic control of intracellular cAMP
title_short PACmn for improved optogenetic control of intracellular cAMP
title_sort pacmn for improved optogenetic control of intracellular camp
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522238/
https://www.ncbi.nlm.nih.gov/pubmed/34663304
http://dx.doi.org/10.1186/s12915-021-01151-9
work_keys_str_mv AT yangshang pacmnforimprovedoptogeneticcontrolofintracellularcamp
AT constantinoanam pacmnforimprovedoptogeneticcontrolofintracellularcamp
AT sachidanandandivya pacmnforimprovedoptogeneticcontrolofintracellularcamp
AT hofmannhannes pacmnforimprovedoptogeneticcontrolofintracellularcamp
AT kunztobiasc pacmnforimprovedoptogeneticcontrolofintracellularcamp
AT kozjakpavlovicvera pacmnforimprovedoptogeneticcontrolofintracellularcamp
AT oertnerthomasg pacmnforimprovedoptogeneticcontrolofintracellularcamp
AT nagelgeorg pacmnforimprovedoptogeneticcontrolofintracellularcamp
AT kittelrobertj pacmnforimprovedoptogeneticcontrolofintracellularcamp
AT geechristinee pacmnforimprovedoptogeneticcontrolofintracellularcamp
AT gaoshiqiang pacmnforimprovedoptogeneticcontrolofintracellularcamp